Posted by linkadge on December 23, 2018, at 6:53:29
In reply to Promising depression drugs to watch for in 2019, posted by Hugh on December 22, 2018, at 15:21:19
Sage-217 is an interesting one. Many of the SSRIs indirectly target the same neurosteroid pathway. As a positive gaba-a modulator, it could also replace the use of benzodiazapines for some people.
I have been benefitting from CBD which is also a positive modulator of the gaba-a receptor.Linkadge
poster:linkadge
thread:1102565
URL: http://www.dr-bob.org/babble/20181024/msgs/1102579.html